Human papillomavirus and induction chemotherapy versus concurrent chemoradiotherapy in locally advanced oropharyngeal cancer: The Dana Farber Experience.

Abstract

BACKGROUND Human papillomavirus (HPV) infection indicates favorable prognosis in oropharyngeal squamous cell carcinoma (SCC). The purpose of this study was for us to assess the impact of HPV in patients treated with sequential therapy versus concomitant chemoradiotherapy (CRT). METHODS Patients with stage III and IVA and B oropharyngeal SCC were reviewed… (More)
DOI: 10.1002/hed.24289

Topics

Cite this paper

@article{Lorch2016HumanPA, title={Human papillomavirus and induction chemotherapy versus concurrent chemoradiotherapy in locally advanced oropharyngeal cancer: The Dana Farber Experience.}, author={Jochen H Lorch and Glenn J. Hanna and Marshall Roy Posner and Anne M O'Neill and Vijaya L Thotakura and Sewanti Atul Limaye and Guilherme Rabinowits and David J Sher and Roy B. Tishler and Robert I. Haddad}, journal={Head & neck}, year={2016}, volume={38 Suppl 1}, pages={E1618-24} }